Professionisti del settore sanitario
Monopolar
Sealers
Il tuo browser è obsoleto
Con un browser aggiornato, l'esperienza di navigazione sul sito Web di Medtronic sarà migliore. Aggiorna il mio browser adesso.
Si, sono un operatore sanitario
Note: Ai sensi e per gli effetti dell’Art. 76 D.P.R. 445/2000 consapevole della responsabilità e delle conseguenze civili e penali previste in caso di dichiarazioni mendaci e/o formazione od uso di atti falsi, nonché in caso di esibizione atti contenenti dati non più corrispondenti a verità e consapevole altresì che qualora emerga la non veridicità del contenuto della presente decadranno i benefici per i quali la stessa è rilasciata confermo di essere un OPERATORE SANITARIO.
I contenuti presenti in questo sito contengono informazioni rivolte agli operatori sanitari, in quanto si riferiscono a prodotti rientranti nella categoria dei dispositivi medici che richiedono l’impiego o l’intervento da parte di professionisti del settore medico-sanitario.
Professionisti del settore sanitario
Monopolar
Sealers
Monopolar sealers feature innovative Transcollation™ technology, a combination of radiofrequency (RF) energy and saline that provides hemostatic sealing of soft tissue and bone during surgery.
Monopolar Sealers
Medtronic built the foundation of its early success on innovative products for solid organ procedures. Studies have shown that using Transcollation™ technology in general surgery procedures provides the following clinical benefits:
Medtronic monopolar sealers are commonly used for these general surgery procedures:
Geller DA, Tsung A, Maheshwari V et al. Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB 2005; 7:208-213.
Urena R, Mendez F, Woods M et al. Laparoscopic partial nephrectomy of solid renal masses without Hilar clamping using a monopolar radiofrequency device. J Urology 2004; 171(3):1054-6.
Blansfield JA, Rapp MM, Chokshi RJ et al. Novel method of stump closure for distal pancreatectomy with a 75% reduction in pancreatic fistula rate. J Gastrointest Surg 2012; 16(3):524-528.
Transcollation™ technology occludes vessels up to 1mm in diameter
Monopolar sealers from Medtronic deliver patented Transcollation™ technology to stop bleeding and reduce blood loss during and after surgery.1,* This technology has been clinically shown to lower transfusion rates and may reduce the need for other blood management products.1,*
Our patented integration of RF energy and saline delivers controlled thermal energy to tissue. This combination allows the device temperature to stay at approximately 100°C – nearly 200°C less than conventional devices, which produces a tissue effect without the charring associated with other methods.
Transcollation™ technology is commonly used for these procedures:
Performance has not been specifically established in all procedures.
Geller DA, Tsung A, et al. Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB, 2005; 7:208-213.
Clinical Benefits of Transcollation™ Technology
Medtronic monopolar sealers provide broad tissue-surface hemostasis in a rapid and controlled manner. Transcollation™ technology has been clinically proven to reduce transfusion rates during and after surgery.1,* MedPAR data has shown that reduced transfusion rates may contribute to lower costs for hospitals2 and reduced length of stay for patients.2,**
* Performance has not been specifically established in all procedures.
** Covance MedPAR report; length of stay has not been specifically correlated with the Aquamantys System.
Geller DA, Tsung A, Maheshwari V et al. Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB 2005; 7:208-213.
Covance report; 2009 MedPAR database based on ICD-9-CM Codes for 100% of Medicare beneficiaries.
Urena R, Mendez F, Woods M et al. Laparoscopic partial nephrectomy of solid renal masses without Hilar clamping using a monopolar radiofrequency device. J Urology 2004; 171(3):1054-6.
Blansfield JA, Rapp MM, Chokshi RJ et al. Novel method of stump closure for distal pancreatectomy with a 75% reduction in pancreatic fistula rate. J Gastrointest Surg 2012; 16(3):524-528.
Transcollation™ technology reduces blood loss during surgery and has been shown to reduce the need for other blood management products such as topical hemostats and energy-based devices.1,* Blood transfusions add costs to surgical procedures through both the direct cost of blood products and the associated increase in average length of stay (LOS) as shown in the tables here.2,**
Transcollation™ technology has been clinically shown to reduce blood transfusion rates during and after liver resections.1,* Medtronic can help you create a customized economic analysis. Please contact your local sales representative for more information.
* Performance has not been specifically established in all procedures.
** Covance MedPAR report; length of stay has not been specifically correlated with the Aquamantys System.
*** Performance has not been specifically established with the Aquamantys System.
Geller DA, Tsung A, Maheshwari V et al. Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB 2005; 7:208-213.
Covance report; 2009 MedPAR database based on ICD-9-CM Codes for 100% of Medicare beneficiaries.
Medtronic Italia S.p.A. Società a socio unico soggetta ad attività di direzione e coordinamento da parte di Medtronic PLC.
Cap. soc. € 1.200.487,00 - Codice fiscale, partita IVA e numero di iscrizione al Registro delle Imprese di Milano-Monza-Brianza-Lodi 09238800156 – REA MI – 1275682. Sede Legale e Uffici Via Varesina, 162 Edificio Raimondi - 20156 Milano.